Biosecurity generally refers to the potential threat to the ecological environment and human health caused by the development and application of modern biotechnology, as well as a series of effective preventive and control measures taken against it. Based on the possible adverse effects of biotechnology development, the concept of biosafety has been put forward. That biosafety concept stock which?
Biosafety concept leading stocks at a glance
1, biological shares (600201), March 2, 2020 interactive platform reply: the company's P3 laboratory will adopt a platform mode of operation, in addition to meet the company's own R & D project demand, but also for the market demand-oriented in vitro high-quality R & D projects and team Joint R&D. At present, the P3 laboratory has completed the R & D project and related resource allocation work, and has recently carried out a number of experimental supplies procurement and transportation work.
2, Haier Biological (688139), the domestic biomedical cryogenic storage leader, the product market share of the country's first; the main biomedical cryogenic storage equipment research and development, production and sales *; the company independently develops and produces biological safety cabinets, clean bench carbon dioxide incubators and other basic laboratory equipment.
3, and then rise science and technology (603601), the company's wholly owned subsidiary, suzhou yuyuan in biosafety and protection of strong competitiveness, has participated in shenlian biological second phase P3 large animal room project as well as dahuayong avian influenza H7N9 inactivated vaccine P3 workshop project.
4, deep sanda A (000032), at present, China's system has undertaken Beijing Institute of Biological Products, Wuhan Institute of Biological Products, Beijing Kexing Biological Products Company Limited, Kangxinuo Biological Joint Stock Company and other companies of the production workshop project. Among them, the vaccine workshop project of Beijing Institute of Biological Products is the first human P3 biopharmaceutical production workshop project in China. The implementation of the above projects will provide technical guarantee and industry reputation for China System to undertake similar projects in the future.
5, CIIC (002051), under the China Zhongyuan has a business chain integrating medical and pension consulting and planning, medical and pension architectural design, cleanliness, biosafety experimental special engineering, general contracting, engineering and medical equipment sets.
6, chutian science and technology (300358), wholly owned subsidiary of sichuan province medical design institute with p3 biosafety laboratory design and construction capacity; new crown epidemic, sichuan province medical design institute to undertake the design of guangzhou eighth people's hospital high-level biosafety laboratory.
7, Xinhua Pharmaceutical (000756), May 27, 2020 the company said on the interactive platform: the company's subsidiary _ Shandong Xinhua Pharmaceutical Co., Ltd. pharmaceutical and chemical design limited company with P2, P3 laboratory design qualification.
8, and good medical (300273), May 26, 2020 the company said in the interactive platform: the company holds the relevant qualifications, can build P2, P3 laboratory.
9, Shangrong Medical (002551), May 27, 2020 interactive platform response: the company currently has a professional team engaged in the design and construction of P3 and the following laboratory, some of the company's products can be used in the P2/P3 laboratory.
10, Sinews Technology (002341), wholly owned subsidiary Shanghai Hankuang is the United States Scientific Instrumentation Laboratory Furniture International Association (SEFA) member companies, with P2, P3 laboratory design and implementation capabilities.
11, Chuangyuan technology (000551), the holding subsidiary of Jiangsu Su net set of beans Limited production of the highest level 3 biological safety cabinets (corresponding to the P4 laboratory), has been used in Central Africa Ebola virus research.
12, Chang Aluminum (002160), the pulse of the medical clean can build clean laboratory business, the pulse of the subsidiary Sichuan Long pulse has been expanding the direction of the hospital clean engineering business
13, Yihua Health (000150), the company's wholly owned subsidiary of ZhongAnKang Logistics Group holds Shenzhen ZhongAnKang medical engineering (85% stake) has purification Engineering professional construction qualification, etc., with the ability to undertake P3 laboratory engineering projects.
14, Imicom (300249), May 27, 2020 interactive platform response: the company's wholly owned subsidiary Sangrex has biological laboratory construction technology and experience.
15, Tailin biological (300813), the company's main business for microbial detection and control technology system products, organic matter, analytical instruments and other pharmaceutical equipment, specific products include all kinds of consumables, instruments and equipment, which can be used individually or in combination in the production of sterile medicines and quality testing.